Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Inv. presentation
|
|
Avidity Biosciences, Inc. (RNA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/17/2023 |
4
| LEVIN ARTHUR A (Director) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Sold 100 shares
@ $22.01, valued at
$2.2k
Exercised 100 options to buy
@ $1.24, valued at
$124 |
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2023 |
4
| Boyce Sarah (President and CEO) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 50,000 shares
@ $0
Granted 400,000 options to buy
@ $22.47, valued at
$9M
|
|
| 01/24/2023 |
4
| Flanagan W. Michael (Chief Technical Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Granted 144,000 options to buy
@ $22.47, valued at
$3.2M
|
|
| 01/24/2023 |
4
| LEVIN ARTHUR A (Chief Scientific Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 18,000 shares
@ $0
Granted 144,000 options to buy
@ $22.47, valued at
$3.2M
|
|
| 01/24/2023 |
4
| MacLean Michael F (CFO) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 18,500 shares
@ $0
Granted 148,000 options to buy
@ $22.47, valued at
$3.3M
|
|
| 01/24/2023 |
4
| McCarthy Teresa (Chief Human Resources Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 108,000 options to buy
@ $22.47, valued at
$2.4M
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2023 |
4
| LEVIN ARTHUR A (Chief Scientific Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Sold 40,000 shares
@ $22.0142, valued at
$880.6k
Exercised 40,000 options to buy
@ $1.24, valued at
$49.6k
|
|
| 08/31/2022 |
4
| LEVIN ARTHUR A (Chief Scientific Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Sold 14,003 shares
@ $22, valued at
$308.1k
Sold 62,498 shares
@ $22.1182, valued at
$1.4M
Sold 3,499 shares
@ $22.0798, valued at
$77.3k
Exercised 14,003 options to buy
@ $0.53, valued at
$7.4k
Exercised 27,740 options to buy
@ $0.53, valued at
$14.7k
Exercised 34,758 options to buy
@ $1.24, valued at
$43.1k
Exercised 3,499 options to buy
@ $1.24, valued at
$4.3k
|
|
| 08/26/2022 |
4
| Boyce Sarah (President and CEO) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Sold 35,045 shares
@ $22.7971, valued at
$798.9k
Sold 14,855 shares
@ $23.069, valued at
$342.7k
Exercised 35,045 options to buy
@ $1.24, valued at
$43.5k
Exercised 14,855 options to buy
@ $1.24, valued at
$18.4k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Mosbrooker Eric (Director) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 22,000 options to buy
@ $12.03, valued at
$264.7k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Henig Noreen (Director) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 22,000 options to buy
@ $12.03, valued at
$264.7k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2022 |
4
| McCarthy Teresa (Chief Human Resources Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 157,500 options to buy
@ $14.22, valued at
$2.2M
|
|
| 03/15/2022 |
4
| Flanagan W. Michael (Chief Technical Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 136,500 options to buy
@ $14.22, valued at
$1.9M
|
|
| 03/15/2022 |
4
| MacLean Michael F (CFO) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 131,250 options to buy
@ $14.22, valued at
$1.9M
|
|
| 03/15/2022 |
4
| LEVIN ARTHUR A (Chief Scientific Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 115,500 options to buy
@ $14.22, valued at
$1.6M
|
|
| 03/15/2022 |
4
| Boyce Sarah (President and CEO) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 425,000 options to buy
@ $14.22, valued at
$6M
|
|
| 11/22/2021 |
4
| LEVIN ARTHUR A (Chief Scientific Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Sold 25,000 shares
@ $27.8887, valued at
$697.2k
Exercised 24,396 options to buy
@ $1.24, valued at
$30.3k
Exercised 604 options to buy
@ $0.53, valued at
$320.1 |
|
| 08/27/2021 |
4
| Mosbrooker Eric (Director) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 30,000 options to buy
@ $20.83, valued at
$624.9k
|
|
| 08/27/2021 |
3
| Mosbrooker Eric (Director) has filed a Form 3 on Avidity Biosciences, Inc. |
| 08/06/2021 |
4
| RTW INVESTMENTS, LP (10% Owner) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Bought 800,000 shares
@ $18, valued at
$14.4M
Converted 3,995,000 preferred shares
@ $0 |
|
| 06/28/2021 |
4
| LEVIN ARTHUR A (Chief Scientific Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Sold 100 shares
@ $27.755, valued at
$2.8k
Sold 17,453 shares
@ $27.9703, valued at
$488.2k
Sold 2,647 shares
@ $29.1398, valued at
$77.1k
Exercised 100 options to buy
@ $1.24, valued at
$124
Exercised 17,017 options to buy
@ $1.24, valued at
$21.1k
Exercised 3,083 options to buy
@ $0.53, valued at
$1.6k
|
|
| 06/22/2021 |
4
| LEVIN ARTHUR A (Chief Scientific Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Sold 200 shares
@ $27.75, valued at
$5.6k
Exercised 200 options to buy
@ $1.24, valued at
$248 |
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| LEVIN ARTHUR A (Chief Scientific Officer) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Sold 14,003 shares
@ $25.9174, valued at
$362.9k
Sold 23,019 shares
@ $26.0249, valued at
$599.1k
|
|
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|